FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim)
RegulatoryapprovedENNUMO™NEULASTA®Positive
AI Analysis
Summary
FDA approved ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's second pegfilgrastim biosimilar, strengthening the company's G-CSF biosimilar portfolio in the U.S. market. This approval provides Accord with two pegfilgrastim biosimilar options plus a filgrastim biosimilar.
Outcome Details
FDA approval of ENNUMO™ (pegfilgrastim-pccg) as Accord BioPharma's second pegfilgrastim biosimilar
Importance:8/10
Sentiment:
0.85
FDA approvalbiosimilarpegfilgrastimG-CSFregulatory approval
Related Companies
Read the original article
Published by PR Newswire Biotech on July 9, 2026 12:05 PM